Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,400.96
(
-0.16%
)
US TECH 100
28,482.00
(
0.68%
)
Dow Jones
49,760.56
(
0.00%
)
Brent Oil
105.56
(
-0.19%
)
Bitcoin
80,502.37
(
0.01%
)
News Focus
News Focus
Post# of 405212
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

noretreat

Send PM Follow Ignore
Followers 127
Posts 11471
Boards Moderated 0
Alias Born 01/06/2010

noretreat

Re: ridinbulls post# 53446

Monday, 02/03/2014 4:40:11 PM

Monday, February 03, 2014 4:40:11 PM

Post# of 405212
I am thinking that to become the standard of care, B needs to be "non-inferior" to daptomycin. Then the extra benefits of single dose, lower resistance and lower threat of resistance really can multiply the potential. I am optimistic about the trial, but it is not without risk.

Wild-I don't think there have been any changes made to B for this trial besides dosage level and frequency...

Men fear thought as they fear nothing else on earth -- more than ruin, more even than death. Thought is subversive and revolutionary, destructive and terrible, thought is merciless to privilege, established institutions, and comfortable habits.(Russell)

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote